886762-86-3 Usage
General Description
4-Bromo-3-fluorophenylene-1,2-diamine and 3,4-Diamino-2-fluorobromobenzene are both chemical compounds belonging to the group of aromatic amines. 4-Bromo-3-fluorophenylene-1,2-diamine is a diamine compound with bromine and fluorine substituents on a phenylene ring. It is used in the synthesis of pharmaceuticals and organic compounds. On the other hand, 3,4-Diamino-2-fluorobromobenzene is a substituted benzene compound with amino, fluorine, and bromine groups. It is used in the production of dyes and pigments, as well as in organic synthesis. Both chemicals are important building blocks in the manufacturing of various products and are utilized in the pharmaceutical, dye, and organic chemistry industries.
Check Digit Verification of cas no
The CAS Registry Mumber 886762-86-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,7,6 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 886762-86:
(8*8)+(7*8)+(6*6)+(5*7)+(4*6)+(3*2)+(2*8)+(1*6)=243
243 % 10 = 3
So 886762-86-3 is a valid CAS Registry Number.
886762-86-3Relevant articles and documents
CHEMICAL COMPOUNDS
-
, (2022/01/23)
-
POLYCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND OR THE COMPOSITION
-
Page/Page column 365, (2020/11/03)
Specific polycyclic compounds, a material for an organic electroluminescence device comprising said specific polycyclic compound, an organic electroluminescence device comprising said specific polycyclic compound, an electronic equipment comprising said organic electroluminescence device, a process for preparing said polycyclic compounds, and the use of said polycyclic compounds in an organic electroluminescence. (Formula I) (I)
PYRIDIN-2-ONE DERIVATIVES OF FORMULA (III) USEFUL AS EP3 RECEPTOR ANTAGONISTS
-
, (2019/02/24)
The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.